SRXH — SRx Health Solutions Balance Sheet
0.000.00%
- $13.40m
- $16.55m
- $6.53m
Annual balance sheet for SRx Health Solutions, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 21.7 | 3.17 | 4.46 | 3.07 | 1.31 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.79 | 6.74 | 4.35 | 7.9 | 3.94 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 43.9 | 27.5 | 16.2 | 15 | 8.13 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.425 | 0.548 | 0.35 | 0.202 | 0.108 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 74.7 | 38.7 | 16.7 | 15.8 | 8.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.34 | 5.58 | 13.7 | 7.15 | 3.54 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 16.8 | 17.1 | 13.8 | 7.15 | 8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 57.9 | 21.5 | 2.98 | 8.65 | 0.407 |
| Total Liabilities & Shareholders' Equity | 74.7 | 38.7 | 16.7 | 15.8 | 8.4 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |